Emergent Biosolutions EBS Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | $75.9M+136% | $139.5M+124% | -$131.6M+76.7% | ||
| $93.9M-11.7% | $95.8M-11.9% | $98.3M-12.5% | $101.3M-11.1% | $106.3M-10.2% | ||
| $16.6M+22.1% | $16.2M-10.0% | $15.2M-14.1% | $12.7M-34.5% | $13.6M-38.7% | ||
| $150.3M— | $172.9M— | —— | —— | —— | ||
| $12.6M-19.7% | $13.8M-39.7% | $11.6M-64.4% | $14M-64.5% | $15.7M-66.8% | ||
| —— | —— | —— | $217.3M— | $195.5M— | ||
| $33.9M— | $24.9M— | $15.8M— | $6.9M— | —— | ||
| -$147.6M+36.3% | -$136.6M+28.3% | -$22.7M+88.1% | -$187.1M-252% | -$231.6M+52.7% | ||
| —— | —— | —— | $200M+582% | $73.8M+120% | ||
| $141.1M— | $162.5M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Emergent Biosolutions generate?
- Emergent Biosolutions (EBS) generated $150.3M in operating cash flow over the trailing twelve months.
- What is Emergent Biosolutions's free cash flow?
- After $12.6M of capital expenditures, Emergent Biosolutions's free cash flow was $141.1M over the trailing twelve months, up 310.0% year over year.
- Where does Emergent Biosolutions's cash flow data come from?
- Every line is extracted from Emergent Biosolutions's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
